ライフサイエンスにおけるAI市場

世界のライフサイエンスにおけるAIの市場規模は、2023年の80億米ドル、2024年の98億米ドルから、予測期間中はCAGR 27.9%で推移し、2029年末には335億米ドルに達すると予測されています。

AIソフトウェアの部門は、2024年の65億米ドルから、CAGR 30.4％で推移し、2029年末には247億米ドルに達すると予測されています。また、AIサービスの部門は、2024年の32億米ドルから、CAGR 22.1%で推移し、2029年末には88億米ドルに達すると予測されています。

当レポートでは、世界のライフサイエンスにおけるAIの市場を調査し、市場概要、市場影響因子および市場機会の分析、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場概要

第2章 市場概要

• 概要
• 創薬におけるAI
• 分子診断におけるAI
• 臨床診断におけるAI
• 臨床試験におけるAI
• 精密医療におけるAI

第3章 市場力学

• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 市場の課題

第4章 新興技術と開発

• 臨床試験
• 臨床試験（ステータス別）
• 臨床試験（研究別）
• 取得特許

第5章 市場セグメンテーション分析

• セグメンテーションの内訳
• 市場分析：製品別
• 世界
• ソフトウェア
• サービス
• 市場分析：用途別
• 市場分析・予測
• 創薬
• 臨床および分子診断
• 臨床試験
• 精密医療と個別化医療
• 市場分析：エンドユーザー別
• 市場分析・予測
• CRO
• 研究センター・学術機関
• 製薬・バイオテクノロジー企業
• 地理的内訳
• 市場分析：地域別
• 世界
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 競合情報

• 主要企業と製品
• 戦略分析
• M&A
• 資金調達

第7章 付録

• 調査手法
• 出典
• 頭字語
• 定義/分類
• 企業プロファイル
• AICURE
• APIXIO
• ATOMWISE INC.
• BENEVOLENTAI
• ENLITIC INC.
• NUMEDII INC.
• RECURSION
• ZEBRA TECHNOLOGIES CORP.

List of Tables

• Summary Table : Global Market for Artificial Intelligence (AI) in Life Sciences, by Product, Through 2029
• Table 1 : Publications Referencing Artificial Intelligence in Life Sciences, 2021-2023
• Table 2 : Artificial Intelligence in Life Science Products from Global Players
• Table 3 : Different Types of Data Used in the Life Science Industry for Artificial Intelligence
• Table 4 : Global Regulatory, Ethical Considerations for Artificial Intelligence in Drug Discovery
• Table 5 : Artificial Intelligence in the Life Sciences: Emerging Technologies
• Table 6 : Selected Clinical Trial Data for Artificial Intelligence in Life Sciences, 2021-2023
• Table 7 : Selected Granted Patents of AI in Life Sciences, 2021-2024
• Table 8 : Global Market for AI in Life Sciences, by Product, Through 2029
• Table 9 : Global Market for AI in Life Sciences, by Application, Through 2029
• Table 10 : Global Market for AI in Life Sciences, by End User, Through 2029
• Table 11 : Global Market for AI in Life Sciences, by Region, Through 2029
• Table 12 : North American Market for AI in Life Sciences, by Country, Through 2029
• Table 13 : North American Market for AI in Life Sciences, by Product, Through 2029
• Table 14 : North American Market for AI in Life Sciences, by Application, Through 2029
• Table 15 : North American Market for AI in Life Sciences, by End User, Through 2029
• Table 16 : European Market for AI in Life Sciences, by Country, Through 2029
• Table 17 : European Market for AI in Life Sciences, by Product, Through 2029
• Table 18 : European Market for AI in Life Sciences, by Application, Through 2029
• Table 19 : European Market for AI in Life Sciences, by End User, Through 2029
• Table 20 : Asia-Pacific Market for AI in Life Sciences, by Country, Through 2029
• Table 21 : Asia-Pacific Market for AI in Life Sciences, by Product, Through 2029
• Table 22 : Asia-Pacific Market for AI in Life Sciences, by Application, Through 2029
• Table 23 : Asia-Pacific Market for AI in Life Sciences, by End User, Through 2029
• Table 24 : Rest of the World Market for AI in Life Sciences, Through 2029
• Table 25 : Rest of the World Market for AI in Life Sciences, by Product, Through 2029
• Table 26 : Rest of the World Market for AI in Life Sciences, by Application, Through 2029
• Table 27 : Rest of the World Market for AI in Life Sciences, by End User, Through 2029
• Table 28 : Top Players and Products in Artificial Intelligence (AI) in Life Science Market
• Table 29 : Mergers and Acquisitions in the Global Market for AI in Life Sciences, 2023-2024
• Table 30 : Fundings in the Global Market for AI Life Sciences, 2022-2024
• Table 31 : Report Information Sources
• Table 32 : Major Acronyms Used in This Report
• Table 33 : AiCure: Company Snapshot
• Table 34 : AiCure: Product Portfolio
• Table 35 : AiCure: News/Key Developments, 2024
• Table 36 : Apixio: Company Snapshot
• Table 37 : Apixio: Product Portfolio
• Table 38 : Apixio: News/Key Developments, 2024
• Table 39 : Atomwise Inc.: Company Snapshot
• Table 40 : Atomwise Inc.: Product Portfolio
• Table 41 : Atomwise Inc.: News/Key Developments, 2022
• Table 42 : BenevolentAI: Company Snapshot
• Table 43 : BenevolentAI: Financial Performance, FY 2022 and 2023
• Table 44 : BenevolentAI: Product Portfolio
• Table 45 : BenevolentAI: News/Key Developments, 2024
• Table 46 : Enlitic Inc.: Company Snapshot
• Table 47 : Enlitic Inc.: Financial Performance, FY 2022 and 2023
• Table 48 : Enlitic Inc.: Product Portfolio
• Table 49 : Enlitic Inc.: News/Key Developments, 2024
• Table 50 : NuMedii Inc.: Company Snapshot
• Table 51 : NuMedii Inc.: Product Portfolio
• Table 52 : NuMedii Inc.: News/Key Developments, 2020
• Table 53 : Recursion: Company Snapshot
• Table 54 : Recursion: Financial Performance, FY 2022 and 2023
• Table 55 : Recursion: Product Portfolio
• Table 56 : Recursion: News/Key Developments, 2023-2024
• Table 57 : Zebra Technologies Corp.: Company Snapshot
• Table 58 : Zebra Technologies Corp.: Financial Performance, FY 2022 and 2023
• Table 59 : Zebra Technologies Corp.: Product Portfolio
• Table 60 : Zebra Technologies Corp.: News/Key Developments, 2024

List of Figures

• Summary Figure : Global Market for Artificial Intelligence (AI) in Life Sciences, by Product, 2021-2029
• Figure 1 : Breakdown of Publications Referencing Artificial Intelligence in Life Sciences, 2021-2023
• Figure 2 : Market Dynamics of Artificial Intelligence in Life Sciences
• Figure 3 : Total Precision Medicine Treatment Spending Worldwide, 2022-2024
• Figure 4 : Share of Clinical Trials in Global AI in Life Sciences Market, by Status, 2020-2024
• Figure 5 : Share of Clinical Trials in Global AI in Life Sciences Market, by Study, 2020-2024
• Figure 6 : Clinical Trials in Global AI in Life Sciences Market, by Interventions, 2020-2024
• Figure 7 : Patents Granted for AI in Life Sciences Market, by Year, 2020-2023
• Figure 8 : Global Market Shares of AI in Life Sciences, by Product, 2023
• Figure 9 : Global Market Shares of AI in Life Sciences, by Application, 2023
• Figure 10 : Global Market Shares of AI in Life Sciences, by End User, 2023
• Figure 11 : Global Market Shares of AI in Life Sciences, by Region, 2023
• Figure 12 : North American Market Shares of AI in Life Sciences, by Country, 2023
• Figure 13 : North American Market Shares of AI in Life Sciences, by Product, 2023
• Figure 14 : North American Market Shares of AI in Life Sciences, by Application, 2023
• Figure 15 : North American Market Shares of AI in Life Sciences, by End User, 2023
• Figure 16 : European Market Shares of AI in Life Sciences, by Country, 2023
• Figure 17 : European Market Shares of AI in Life Sciences, by Product, 2023
• Figure 18 : European Market Shares of AI in Life Sciences, by Application, 2023
• Figure 19 : European Market Shares of AI in Life Sciences, by End User, 2023
• Figure 20 : Asia-Pacific Market Shares of AI in Life Sciences, by Country, 2023
• Figure 21 : Asia-Pacific Market Shares of AI in Life Sciences, by Product, 2023
• Figure 22 : Asia-Pacific Market Shares of AI in Life Sciences, by Application, 2023
• Figure 23 : Asia-Pacific Market Shares of AI in Life Sciences, by End User, 2023
• Figure 24 : Rest of the World Market Shares of AI in Life Sciences, by Product, 2023
• Figure 25 : Rest of the World Market Shares of AI in Life Sciences, by Application, 2023
• Figure 26 : Rest of the World Market Shares of AI in Life Sciences, by End User, 2023
• Figure 27 : BenevolentAI: Revenue Share, by Country/Region, FY 2023
• Figure 28 : Enlitic Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 29 : Enlitic Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 30 : Zebra Technologies Corp.: Revenue Share, by Business Unit, FY 2023

The global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023. The market is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.

The global market for AI in life sciences software is estimated to grow from $6.5 billion in 2024 to $24.7 billion by the end of 2029, at a CAGR of 30.4% from 2024 to 2029.

The global market for AI in life sciences services is estimated to grow from $3.2 billion in 2024 to $8.8 billion by the end of 2029, at a CAGR of 22.1% from 2024 to 2029.

Report Scope:

This report aims to comprehensively study the market size of global artificial intelligence (AI) in the life sciences. Current and historical market revenues can be estimated based on products, applications, end users, and regions.

Report Includes:

• 26 data tables and 35 additional tables
• Analyses of trends in the global market for AI in life sciences, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the current market size and revenue prospects, along with a market share analysis based on product segment, application, end user and region
• Facts and figures pertaining to the market dynamics, current and emerging technologies, regulatory scenario and the expected impact of macroeconomic factors
• Identification of the AI products and technologies with the highest commercial potential, and their relevant applications in life sciences, specifically precision medicine and personalized healthcare
• Overview of ESG developments and sustainability trends, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
• Review of patent activity and key patent grants
• An analysis of the industry structure, including companies' market shares, merger and acquisition activity, and venture funding outlook
• Profiles of the leading companies, including AiCure LLC., Apixio Inc., Atomwise Inc., BenevolentAI and NuMedii Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Artificial Intelligence in Drug Discovery
• Artificial Intelligence in Molecular Diagnostics
• Artificial Intelligence in Clinical Diagnostics
• Artificial Intelligence in Clinical Trials
• Artificial Intelligence in Precision Medicine

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges

Chapter 4 Emerging Technologies and Developments

• Introduction
• Clinical Trials
• Clinical Trials, by Status
• Clinical Trials, by Study
• Granted Patents

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis, by Product
• Global
• Software
• Services
• Market Analysis, by Application
• Market Analysis and Forecast
• Drug Discovery
• Clinical and Molecular Diagnostics
• Clinical Trials
• Precision and Personalized Medicine
• Market Analysis, by End User
• Market Analysis and Forecast
• Contract Research Organizations
• Research Centers and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Geographic Breakdown
• Market Analysis, by Region
• Global
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Top Players and Products
• Strategic Analysis
• Mergers and Acquisitions
• Funding

Chapter 7 Appendix

• Methodology
• Sources
• Acronyms
• Definitions/Taxonomy
• Company Profiles
• AICURE
• APIXIO
• ATOMWISE INC.
• BENEVOLENTAI
• ENLITIC INC.
• NUMEDII INC.
• RECURSION
• ZEBRA TECHNOLOGIES CORP.